|Symbol||Date||Last||Change $||Change %||Low||High||Avg. volume||Mkt cap|
The Company’s business model capitalizes on inventions and technology from which profits could be earned primarily through licensing. MHTX is dedicated to earning profit for its 8,600 owner-shareholders by identifying, developing, patenting, supporting and marketing technical innovation by harvesting top technology talent to bring game-changing products to market.
Manhattan Scientifics, Inc. is located in New Mexico, New York and Montreal. It is focused on technology transfer and commercialization of disruptive technologies in the nano medicine space. The company is presently developing commercial medical prosthetics applications for its ultra-fine grain metals and plans to commercialize the cancer research work and nanomedical applications developed by Senior Scientific LLC, a unit of the Company.
Manhattan Scientifics, Inc. assists and acquires early stage technologies and assists entrepreneurial founders and management to stage them to become commercial.Our investment philosophy is defined by our desire to help build innovative companies with exceptional potential. We emphasize novel technologies in the nanomedicine space with the potential to be disruptive and the ability to establish sustainable businesses. We are patient capital with experienced business-building partners who bring the perspective of merchant-bankers not venture capitalists. Our approach to assist scientists to commercialize their work is by providing a forum within which the commercialization process is fostered through partnerships with existing companies (Fortune 1000 or larger). The entrepreneurial scientists and engineers who join us create personal success and wealth on an accelerated basis by virtue of ownership of publicly traded Manhattan Scientifics shares (MHTX).